industry

India's Shilpa Medicare can make 100-200 million doses of COVID-19 shot, says executive



The company’s shares jumped as much as 9.2% on India’s National Stock Exchange following the news.



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.